Journal of Clinical Epidemiology
Volume 62, Issue 12 , Pages 1233-1241, December 2009

Instrumental variables II: instrumental variable application—in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance

  • Jeremy A. Rassen

      Affiliations

    • Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham & Women's Hospital, Boston, MA, USA
    • Harvard Medical School, Boston, MA, USA
    • Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA
    • Corresponding Author InformationCorresponding author. Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham & Women's Hospital, 1620, Tremont Street, Suite 3030, Boston, MA 02120, USA.
  • ,
  • M. Alan Brookhart

      Affiliations

    • Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham & Women's Hospital, Boston, MA, USA
    • Harvard Medical School, Boston, MA, USA
  • ,
  • Robert J. Glynn

      Affiliations

    • Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham & Women's Hospital, Boston, MA, USA
    • Harvard Medical School, Boston, MA, USA
    • Department of Biostatistics, Harvard School of Public Health, Boston, MA, USA
  • ,
  • Murray A. Mittleman

      Affiliations

    • Harvard Medical School, Boston, MA, USA
    • Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA
    • Cardiovascular Epidemiology Research Group, Beth Israel Deaconess Medical Center, Boston, MA, USA
  • ,
  • Sebastian Schneeweiss

      Affiliations

    • Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham & Women's Hospital, Boston, MA, USA
    • Harvard Medical School, Boston, MA, USA
    • Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA

Accepted 14 December 2008. published online 06 April 2009.

Abstract 

Objective

An instrumental variable (IV) is an unconfounded proxy for a study exposure that can be used to estimate a causal effect in the presence of unmeasured confounding. To provide reliably consistent estimates of effect, IVs should be both valid and reasonably strong. Physician prescribing preference (PPP) is an IV that uses variation in doctors' prescribing to predict drug treatment. As reduction in covariate imbalance may suggest increased IV validity, we sought to examine the covariate balance and instrument strength in 25 formulations of the PPP IV in two cohort studies.

Study Design and Setting

We applied the PPP IV to assess antipsychotic medication (APM) use and subsequent death among two cohorts of elderly patients. We varied the measurement of PPP, plus performed cohort restriction and stratification. We modeled risk differences with two-stage least square regression. First-stage partial r2 values characterized the strength of the instrument. The Mahalanobis distance summarized balance across multiple covariates.

Results

Partial r2 ranged from 0.028 to 0.099. PPP generally alleviated imbalances in nonpsychiatry-related patient characteristics, and the overall imbalance was reduced by an average of 36% (±40%) over the two cohorts.

Conclusion

In our study setting, most of the 25 formulations of the PPP IV were strong IVs and resulted in a strong reduction of imbalance in many variations. The association between strength and imbalance was mixed.

Keywords: Pharmacoepidemiology, Antipsychotic agents, Instrumental variable, Mahalanobis distance, Partial R-squared, Confounding factor (epidemiology), Physician prescribing preference

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0895-4356(09)00013-4

doi:10.1016/j.jclinepi.2008.12.006

Journal of Clinical Epidemiology
Volume 62, Issue 12 , Pages 1233-1241, December 2009